Сравнение

Pasireotid vs. Sincalide

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

396091-73-9

25126-32-3

Молекулярная масса

1047.21 g/mol

1143.29 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2

Механизм действия

Pasireotid

Pasireotide binds more broadly than older somatostatin analogs (SSTR1/2/3/5) with particularly high affinity for SSTR5. This suppresses, among others, ACTH release in Cushing's disease and GH release in acromegaly.

Sincalide

Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследование на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Pasireotid	Sincalide
Германия	Рецептурный	Неясно
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Pasireotid and Sincalide?: Pasireotid is classified as "Исследования (прочее)", while Sincalide is classified as "Исследования (прочее)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Pasireotid or Sincalide?: The highest available evidence level is "РКИ на людях" for Pasireotid and "Исследование на людях" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Pasireotid and Sincalide in Germany and the United States?: Германия: Pasireotid — Рецептурный, Sincalide — Неясно. США: Pasireotid — Рецептурный, Sincalide — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Pasireotid

Sincalide

Германия

Рецептурный

Неясно

США

Рецептурный

Frequently asked questions

What is the difference between Pasireotid and Sincalide?

Pasireotid is classified as "Исследования (прочее)", while Sincalide is classified as "Исследования (прочее)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Pasireotid or Sincalide?

The highest available evidence level is "РКИ на людях" for Pasireotid and "Исследование на людях" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Pasireotid and Sincalide in Germany and the United States?

Германия: Pasireotid — Рецептурный, Sincalide — Неясно. США: Pasireotid — Рецептурный, Sincalide — Рецептурный. These are factual summaries with source and review date on the individual pages.